Article | August 4, 2021

Container Closure Integrity: A Risk-Based Approach To Ensure Drug Product Quality

By Fran DeGrazio and T. Page McAndrew, West Pharmaceutical Services, Inc.

iStock-1268181219-glass-vial-packaging-sterile

Qualification, and demonstration of fit-for-purpose, for a drug product vial/stopper/seal primary package system comprises many factors: protection, compatibility, safety, and performance.

One of the subcategories is container closure integrity (CCI), which is the topic of this article. CCI is essential to protect the drug product through shelf life, and to demonstrate an integral system to regulatory agencies.

Historically, leakage of the primary package system has been a major reason for FDA field alerts. (3) To try to address this and other issues, in 2016 the United States Pharmacopeial Convention (USP) published a guidance: Chapter <1207> Sterile Product – Package Integrity Evaluation. (4) Therein a new concept was defined: maximum allowable leakage limit (MALL). MALL is the greatest rate that can be accepted for a primary package system and drug product; it is unique to each system. A system has integrity, i.e., CCI, if it allows no leak rate greater than the MALL. In other words, the system prevents product/potency loss, prevents microorganism ingress, and suitably limits entry of detrimental substances, thus ensuring drug product quality. To determine MALL, numerous factors must be considered, e.g., drug sensitivity to oxygen ingress.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

West Pharmaceutical Services, Inc.